Literature DB >> 10971524

Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen.

E Yiannaki1, P G Vlachoyiannopoulos, M N Manoussakis, C Sakarellos, M Sakarellos-Daitsiotis, H M Moutsopoulos, A G Tzioufas.   

Abstract

The aim of this study was to investigate the immunogenicity of four synthetic peptides, representing linear B cell epitopes of the human La/SSB autoantigen: 145-164 aa (p1), 289-308 aa (p2), 301-318 aa (p3) and 349-364 aa (p4), in rabbits. New Zealand White rabbits were immunized with each of the above peptides attached in four copies on tetrameric sequential oligopeptide carriers (SOC) in duplicate. Control immunizations were also performed (one rabbit each, immunized with Freud's complete adjuvant alone or with the SOC carrier alone). Animals were bled at regular intervals and sera were analysed for anti-La/SSB activity by ELISA assays using as antigen the various synthetic peptides, as well as the whole La/SSB protein. Four months after the last immunization, the animals were killed and peripheral blood mononuclear and spleen cells were co-cultured with either the peptides, the SOC carrier, or 27 peptides, covering the entire length of the human La/SSB molecule (23 amino acids long, overlapping by eight residues to each other). A specific, IgG, anti-peptide antibody response was detected, initially directed against the priming peptide, and subsequently expanded to the other La/SSB synthetic peptides. The antibody titres remained high, even 4 months after the last immunization. Sera from rabbits immunized with either p2 or p3 reacted also with the whole La/SSB protein, as was demonstrated by ELISA and immunoblot assays. No reactivities against either Ro60 or Ro52 autoantigen were found. Rabbit spleen cell reacted not only with the epitope used for the immunization but also with other La/SSB peptides. Immunization of rabbits with the major human La/SSB B cell antigenic determinants, linked to SOC carrier, induces strong and sustained antibody and T cell responses against multiple epitopes of the human La/SSB protein. Thus, La/SSB B cell linear epitopes are probably capable also of functioning as T cell epitopes, in this experimental animal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971524      PMCID: PMC1905730          DOI: 10.1046/j.1365-2249.2000.01326.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

Review 1.  Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.

Authors:  R H Scofield; A D Farris; A C Horsfall; J B Harley
Journal:  Arthritis Rheum       Date:  1999-02

Review 2.  Self antigens and epitope spreading in systemic autoimmunity.

Authors:  J Craft; S Fatenejad
Journal:  Arthritis Rheum       Date:  1997-08

3.  No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs).

Authors:  P G Vlachoyiannopoulos; C Petrovas; A G Tzioufas; C Alexopoulos; V Tsikaris; A Guialis; L Nakopoulou; M Sakarellos-Daitsiotis; C Sakarellos; P Davaris; H M Moutsopoulos
Journal:  J Autoimmun       Date:  2000-02       Impact factor: 7.094

4.  The value of synthetic linear epitope analogues of La/SSB for the detection of autoantibodies to La/SSB; specificity, sensitivity and comparison of methods.

Authors:  E E Yiannaki; A G Tzioufas; M Bachmann; J Hantoumi; V Tsikaris; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterization.

Authors:  A G Tzioufas; E Yiannaki; M Sakarellos-Daitsiotis; J G Routsias; C Sakarellos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1997-05       Impact factor: 4.330

6.  Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse.

Authors:  R H Scofield; K M Kaufman; U Baber; J A James; J B Harley; B T Kurien
Journal:  Arthritis Rheum       Date:  1999-05

7.  Induction of autoimmunity by multivalent immunodominant and subdominant T cell determinants of La (SS-B).

Authors:  A D Farris; L Brown; P Reynolds; J B Harley; J A James; R H Scofield; J McCluskey; T P Gordon
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

8.  Use of sequential oligopeptide carriers (SOCn) in the design of potent Leishmania gp63 immunogenic peptides.

Authors:  V Tsikaris; C Sakarellos; M Sakarellos-Daitsiotis; M T Cung; M Marraud; G Konidou; A Tzinia; K P Soteriadou
Journal:  Pept Res       Date:  1996 Sep-Oct

9.  Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome.

Authors:  J B Harley; E L Alexander; W B Bias; O F Fox; T T Provost; M Reichlin; H Yamagata; F C Arnett
Journal:  Arthritis Rheum       Date:  1986-02

10.  Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice.

Authors:  P Reynolds; T P Gordon; A W Purcell; D C Jackson; J McCluskey
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  7 in total

1.  Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets.

Authors:  E A Stea; J G Routsias; M Samiotaki; G Panayotou; E Papalambros; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.

Authors:  A G Terzoglou; J G Routsias; S Avrameas; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

3.  Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.

Authors:  N C Kyriakidis; E K Kapsogeorgou; V C Gourzi; O D Konsta; G E Baltatzis; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

4.  RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP.

Authors:  John G Routsias; Nikolaos Kyriakidis; Michael Latreille; Athanasios G Tzioufas
Journal:  Mol Med       Date:  2009-10-14       Impact factor: 6.354

5.  T cell help is required to induce idiotypic-anti-idiotypic autoantibody network after immunization with complementary epitope 289-308aa of La/SSB autoantigen in non-autoimmune mice.

Authors:  M G Papamattheou; J G Routsias; E E Karagouni; C Sakarellos; M Sakarellos-Daitsiotis; H M Moutsopoulos; A G Tzioufas; E N Dotsika
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

6.  Evidence for intramolecular B-cell epitope spreading during experimental immunization with an immunogenic thyroglobulin peptide.

Authors:  A Thrasyvoulides; P Lymberi
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

7.  Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.

Authors:  A G Tzioufas; R Wassmuth; U G Dafni; A Guialis; H-J Haga; D A Isenberg; R Jonsson; J R Kalden; H Kiener; C Sakarellos; J S Smolen; N Sutcliffe; C Vitali; E Yiannaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.